Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 41 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 6284778

    Methods and compositions for stimulating neurite growth

    Vertex Pharmaceuticals Incorporated · Granted Sep 4, 2001 · Expires Aug 30, 2021

    expired

  2. US 6268384

    Compounds possessing neuronal activity

    Vertex Pharmaceuticals Incorporated · Granted Jul 31, 2001 · Expires Jul 26, 2021

    expired

  3. US 6265380

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 24, 2001 · Expires Jul 19, 2021

    expired

  4. US 6258948

    Inhibitors of Interleukin-1.beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2001 · Expires Jul 5, 2021

    expired

  5. US 6225350

    Butyrate prodrugs derived from lactic acid

    Vertex Pharmaceuticals Incorporated · Granted May 1, 2001 · Expires Apr 26, 2021

    expired

  6. US 6204261

    Inhibitors of interleukin-1.beta. Converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 20, 2001 · Expires Mar 15, 2021

    expired

  7. US 6172086

    Methods and compositions for stimulating neurite growth

    Vertex Pharmaceuticals Incorporated · Granted Jan 9, 2001 · Expires Jan 4, 2021

    expired

  8. US 6162800

    N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2000 · Expires Dec 14, 2020

    expired

  9. US 6162790

    Inhibitors of interleukin-1.beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2000 · Expires Dec 14, 2020

    expired

  10. US 6147080

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Nov 14, 2000 · Expires Nov 9, 2020

    expired

  11. US 6136787

    Interleukin 1.beta. protease and interleukin 1.beta. protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 24, 2000 · Expires Oct 19, 2020

    expired

  12. US 6127372

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2000 · Expires Sep 28, 2020

    expired

  13. US 6128582

    Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2000 · Expires Sep 28, 2020

    expired

  14. US 6124328

    Methods and compositions for stimulating neurite growth

    Vertex Pharmaceuticals Incorporated · Granted Sep 26, 2000 · Expires Sep 21, 2020

    expired

  15. US 6121266

    Pyridazines as interleukin-1.beta. converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 19, 2000 · Expires Sep 14, 2020

    expired

  16. US 6103711

    Inhibitors of interleukin-1.beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Aug 15, 2000 · Expires Aug 10, 2020

    expired

  17. US 6054472

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired

  18. US 6037370

    Methods and compositions for stimulating neurite growth

    Vertex Pharmaceuticals Incorporated · Granted Mar 14, 2000 · Expires Mar 9, 2020

    expired

  19. US 6025147

    Inhibitors of interleukin-1 .beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 15, 2000 · Expires Feb 10, 2020

    expired

  20. US 6011001

    Method of protein therapy by orally administering crosslinked protein crystals

    Vertex Pharmaceuticals Incorporated · Granted Jan 4, 2000 · Expires Dec 30, 2019

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.